PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1684473

Functionally different Langerhans' cells in human epidermis.

K Warfvinge·A Mikulowska·B Falck
View original source ↗Export metadata ↓

Abstract

Experiments comparing the L-dopa histofluorescence method for the visualization of epidermal Langerhans' cells and immunocytochemical labelling with monoclonal anti-T6 antibodies have demonstrated the existence of two functionally different human Langerhans' cells: those that take up L-dopa by a mediated transport and those that lack the capacity to take up L-dopa.

Explore related subjects

Biological TransportCell CountEpidermal CellsHumansImmunohistochemistryLangerhans CellsLevodopaMicroscopy, FluorescenceModels, BiologicalComparative StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Warfvinge, A Mikulowska, B Falck. 1991. Functionally different Langerhans' cells in human epidermis.. https://pubmed.ncbi.nlm.nih.gov/1684473/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Evidence of a glucose proton motive force-dependent permease and a fructose phosphoenolpyruvate:phosphotransferase transport system in Lactobacillus reuteri CRL 1098.

Sugar uptake and phosphoenolpyruvate phosphorylation assays have shown that the heterofermentative strain Lactobacillus reuteri CRL 1098, of likely probiotic value, can transport D-fructose through an inducible fructose-specific phosphotransferase system (K(m) 95 microM) and D-glucose mainly through a proton motive force-driven permease. These data open new perspectives for metabolic and regulatory studies in this bacterium.

Biological Transport↗
PubMed1999

Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha.

Estrogen receptor alpha (ERalpha) is a soluble protein that mediates the effects of the gonadal estrogens such as 17beta-estradiol. Upon ligand binding, a cytoplasmic pool of ERalpha translocates to the nucleus, where it acts as a transcription factor, driving the expression of genes that contain estrogen-response elements. The activity of ERalpha is regulated by a number of proteins, including cytosolic chaperones and nuclear cofactors. Here, we show that caveolin-1 potentiates ERalpha-mediated signal transduction. Coexpression of caveolin-1 and ERalpha resulted in ligand-independent translocation of ERalpha to the nucleus as shown by both cell fractionation and immunofluorescence microscopic studies. Similarly, caveolin-1 augmented both ligand-independent and ligand-dependent ERalpha signaling as measured using a estrogen-response element-based luciferase reporter assay. Caveolin-1-mediated activation of ERalpha was sensitive to a well known ER antagonist, 4-hydroxytamoxifen. However, much higher concentrations of tamoxifen were required to mediate inhibition in the presence of caveolin-1. Interestingly, caveolin-1 expression also synergized with a constitutively active, ligand-independent ERalpha mutant, dramatically illustrating the potent stimulatory effect of caveolin-1 in this receptor system. Taken together, our results identify caveolin-1 as a new positive regulator of ERalpha signal transduction.

Biological Transport↗